Glen Burnie, MD, United States of America

Mary Emma Gorham Bigelow

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mary Emma Gorham Bigelow: Innovator in Neurochemical Sensing

Introduction

Mary Emma Gorham Bigelow is a notable inventor based in Glen Burnie, MD (US). She has made significant contributions to the field of neurochemical sensing, particularly through her innovative patent. Her work focuses on the development of advanced biosensors that can measure neurochemicals in real-time.

Latest Patents

Mary Emma Gorham Bigelow holds a patent for an in vivo biosensor. This invention comprises an implantable probe designed for the rapid measurement of multiple neurochemicals at the cellular scale within the brain. The ability to detect various chemicals in vivo, whether in animals or humans, enhances the understanding of acute neurochemical changes that occur within seconds. The neurotransmitter chemical sensing platform allows for continuous in vivo monitoring during trials of psychoactive drugs in laboratory animals. The high spatial resolution of the probe enables chemical detection around small groups of neurons, aiding in the isolation of endogenous activity from different neuron types affected by disease states. Additionally, neurochemical detection can measure tissue responses to external stimuli, such as the pharmacodynamics of drugs. The combination of high temporal and spatial resolutions, along with multi-neurochemical sensing, facilitates detailed studies on the brain's response to both internal and external stimuli.

Career Highlights

Throughout her career, Mary Emma Gorham Bigelow has demonstrated a commitment to advancing neurochemical research. Her innovative approach to biosensing has positioned her as a leader in her field. She has successfully translated her research into practical applications that can significantly impact neuroscience and pharmacology.

Collaborations

Mary Emma Gorham Bigelow collaborates with Brian Jamieson, contributing to the development and refinement of her biosensing technologies. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Mary Emma Gorham Bigelow's contributions to neurochemical sensing through her patented in vivo biosensor highlight her role as a pioneering inventor. Her work not only enhances scientific understanding but also paves the way for future advancements in neuroscience.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…